BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28025250)

  • 1. Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.
    Movahedin M; Brooks TM; Supekar NT; Gokanapudi N; Boons GJ; Brooks CL
    Glycobiology; 2017 Jul; 27(7):677-687. PubMed ID: 28025250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.
    Zhou D; Xu L; Huang W; Tonn T
    Molecules; 2018 May; 23(6):. PubMed ID: 29857542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope.
    Singh J; Her C; Supekar N; Boons GJ; Krishnan VV; Brooks CL
    J Pept Sci; 2020 Jan; 26(1):e3229. PubMed ID: 31729101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine.
    Qi W; Schultes BC; Liu D; Kuzma M; Decker W; Madiyalakan R
    Hybrid Hybridomics; 2001; 20(5-6):313-24. PubMed ID: 11839249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
    Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
    Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.
    Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ
    Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
    Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
    Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody.
    Matsushita T; Ohyabu N; Fujitani N; Naruchi K; Shimizu H; Hinou H; Nishimura S
    Biochemistry; 2013 Jan; 52(2):402-14. PubMed ID: 23259747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glycosylation on MUC1 humoral immune recognition: NMR studies of MUC1 glycopeptide-antibody interactions.
    Grinstead JS; Koganty RR; Krantz MJ; Longenecker BM; Campbell AP
    Biochemistry; 2002 Aug; 41(31):9946-61. PubMed ID: 12146959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
    Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
    Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 glycopeptide epitopes predicted by computational glycomics.
    Song W; Delyria ES; Chen J; Huang W; Lee JS; Mittendorf EA; Ibrahim N; Radvanyi LG; Li Y; Lu H; Xu H; Shi Y; Wang LX; Ross JA; Rodrigues SP; Almeida IC; Yang X; Qu J; Schocker NS; Michael K; Zhou D
    Int J Oncol; 2012 Dec; 41(6):1977-84. PubMed ID: 23023583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
    Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
    Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
    Dai J; Allard WJ; Davis G; Yeung KK
    Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody.
    Martínez-Sáez N; Castro-López J; Valero-González J; Madariaga D; Compañón I; Somovilla VJ; Salvadó M; Asensio JL; Jiménez-Barbero J; Avenoza A; Busto JH; Bernardes GJ; Peregrina JM; Hurtado-Guerrero R; Corzana F
    Angew Chem Int Ed Engl; 2015 Aug; 54(34):9830-4. PubMed ID: 26118689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1).
    Karsten U; Serttas N; Paulsen H; Danielczyk A; Goletz S
    Glycobiology; 2004 Aug; 14(8):681-92. PubMed ID: 15115750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1.
    Schoonooghe S; Burvenich I; Vervoort L; De Vos F; Mertens N; Grooten J
    Protein Eng Des Sel; 2010 Sep; 23(9):721-8. PubMed ID: 20616115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
    Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray Analysis of Antibodies Induced with Synthetic Antitumor Vaccines: Specificity against Diverse Mucin Core Structures.
    Pett C; Cai H; Liu J; Palitzsch B; Schorlemer M; Hartmann S; Stergiou N; Lu M; Kunz H; Schmitt E; Westerlind U
    Chemistry; 2017 Mar; 23(16):3875-3884. PubMed ID: 27957769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.